Is Beta-Blocker Treatment Associated with a Decrease in the Risk of Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|3|9|653-661

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.3, Iss.9, 2006-11, pp. : 653-661

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Which Beta-Blocker is Most Effective in Heart Failure?

By Remme Willem  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 4, 2010-08 ,pp. : 351-358

Springer Publishing Company

Access to resources Recommend Favorite

Effects of the beta-blocker propranolol on cued and contextual fear conditioning in humans

By Grillon Christian   Cordova Jeremy   Morgan Charles   Charney Dennis   Davis Michael  

Psychopharmacology, Vol. 175, Iss. 3, 2004-09 ,pp. : 342-352

Springer Publishing Company

Access to resources Recommend Favorite

Acute Beta Blocker Overdose: Factors Associated with the Development of Cardiovascular Morbidity

By Love Jeffrey  

Journal of Toxicology. Clinical Toxicology, Vol. 38, Iss. 3, 2000-01 ,pp. : 275-281

Informa Healthcare

Access to resources Recommend Favorite

Do Standardized Beta-Blocker Titration Protocols in Heart Failure Improve Compliance? The GESICA Registry Experience

By Remme Willem  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 2, 2005-03 ,pp. : 99-101

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Tolerability of Nisoldipine Coat-Core vs Diltiazem Retard in Combination with a Beta-Blocker in Patients with Stable Exertional Angina Pectoris

By Melcher A.  

Clinical Drug Investigation, Vol. 15, Iss. 5, 1998-05 ,pp. : 389-396

Adis International

Access to resources Recommend Favorite